Ireland organic chemicals over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 2937 Hormones, prostaglandins, thromboxanes and leukotrienes… | US$18.4 billion | 44.9% |
| 2933 Heterocyclic compounds with nitrogen hetero-atom(s) only | US$13.1 billion | 32.0% |
| 2934 Nucleic acids and their salts, whether or not chemicall… | US$5.3 billion | 12.9% |
| 2935 Sulphonamides | US$2.6 billion | 6.3% |
| 2932 Heterocyclic compounds with oxygen hetero-atom(s) only | US$798.9 million | 1.9% |
| 2922 Oxygen-function amino-compounds | US$154.0 million | 0.4% |
| 2941 Antibiotics | US$112.8 million | 0.3% |
| 2924 Carboxyamide-function compounds | US$93.5 million | 0.2% |
| 2918 Acids | US$64.1 million | 0.2% |
| 2903 Halogenated derivatives of hydrocarbons | US$61.7 million | 0.2% |
| Product | Value | Share |
|---|---|---|
| 293799 Hormones and steroids used primarily as hormones: (other than insulin and its salts, oestrogens and progestogens) | US$18.4 billion | 44.9% |
| 293359 Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | US$5.7 billion | 14.0% |
| 293490 Heterocyclic compounds: n.e.s. in chapter 29 | US$5.2 billion | 12.7% |
| 293379 Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | US$3.7 billion | 9.1% |
| 293500 Sulphonamides | US$2.6 billion | 6.3% |
| 293390 Heterocyclic compounds: n.e.s. in heading no. 2933 | US$1.5 billion | 3.6% |
| 293319 Heterocyclic compounds: containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than those of item no. 2933.11 | US$956.8 million | 2.3% |
| 293339 Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | US$811.4 million | 2.0% |
| 293290 Heterocyclic compounds: n.e.s. in heading no. 2932 | US$684.4 million | 1.7% |
| 293340 Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused | US$365.5 million | 0.9% |
| Heading | Value | Share |
|---|---|---|
| 2933 Heterocyclic compounds with nitrogen hetero-atom(s) only | US$4.1 billion | 49.1% |
| 2934 Nucleic acids and their salts, whether or not chemicall… | US$1.6 billion | 19.1% |
| 2924 Carboxyamide-function compounds | US$915.6 million | 10.9% |
| 2922 Oxygen-function amino-compounds | US$279.1 million | 3.3% |
| 2932 Heterocyclic compounds with oxygen hetero-atom(s) only | US$274.0 million | 3.3% |
| 2918 Acids | US$117.2 million | 1.4% |
| 2941 Antibiotics | US$98.2 million | 1.2% |
| 2905 Acyclic alcohols and their halogenated, sulphonated, ni… | US$96.6 million | 1.1% |
| 2937 Hormones, prostaglandins, thromboxanes and leukotrienes… | US$86.6 million | 1.0% |
| 2935 Sulphonamides | US$85.0 million | 1.0% |
| Product | Value | Share |
|---|---|---|
| 293379 Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | US$2.8 billion | 32.8% |
| 293490 Heterocyclic compounds: n.e.s. in chapter 29 | US$1.3 billion | 15.7% |
| 292429 Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | US$879.9 million | 10.5% |
| 293390 Heterocyclic compounds: n.e.s. in heading no. 2933 | US$616.0 million | 7.3% |
| 293359 Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | US$458.9 million | 5.5% |
| 293410 Heterocyclic compounds: containing an unfused thiazole ring (whether or not hydrogenated) in the structure | US$291.0 million | 3.5% |
| 293290 Heterocyclic compounds: n.e.s. in heading no. 2932 | US$212.4 million | 2.5% |
| 293339 Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | US$204.3 million | 2.4% |
| 292250 Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function | US$176.7 million | 2.1% |
| 294190 Antibiotics: n.e.s. in heading no. 2941 | US$85.2 million | 1.0% |
Shares are of Ireland's organic chemicals in the same direction. See Organic chemicals for all countries or all of Ireland's trade.
More Ireland products
- 30 Pharmaceutical products
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 85 Electrical machinery and equipment and parts thereof
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 88 Aircraft, spacecraft, and parts thereof
- 33 Essential oils and resinoids
- 27 Mineral fuels, mineral oils and products of their distillation
- 87 Vehicles
- 39 Plastics and articles thereof
- 04 Dairy produce
- 02 Meat and edible meat offal
- 38 Chemical products n.e.c.
Ireland organic chemicals: questions and answers
How much organic chemicals does Ireland export?
In 2024, Ireland exported US$41.0 billion of organic chemicals (HS chapter 29), 15.8% of its total exports. That ranks it 4 of 201 exporting countries in the data.
What are Ireland's biggest organic chemicals exports?
In 2024, the largest 4-digit headings were Hormones, prostaglandins, thromboxanes and leukotrienes… (2937, US$18.4 billion), Heterocyclic compounds with nitrogen hetero-atom(s) only (2933, US$13.1 billion), Nucleic acids and their salts, whether or not chemicall… (2934, US$5.3 billion).
How much organic chemicals does Ireland import?
In 2024, Ireland imported US$8.4 billion of organic chemicals (HS chapter 29), 6.1% of its total imports. That ranks it 17 of 225 importing countries in the data.
What are Ireland's biggest organic chemicals imports?
In 2024, the largest 4-digit headings were Heterocyclic compounds with nitrogen hetero-atom(s) only (2933, US$4.1 billion), Nucleic acids and their salts, whether or not chemicall… (2934, US$1.6 billion), Carboxyamide-function compounds (2924, US$915.6 million).
